Provided herein is a novel composition for oral administration and delivery of Noble gas, such as xenon or argon. Methods of treating and preventing neuronal or cardiovascular damage with such compositions are also provided.

Provided herein is a novel composition for oral administration and delivery of Noble gas, such as xenon or argon. Methods of treating and preventing neuronal or cardiovascular damage with such compositions are also provided.

Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.

Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.

Use of a compound having the formula (1) (2) (3) (4) or, or combinations thereof, for providing a source of butyrate with improved organoleptic properties wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are independently a long chain fatty acid having between 16 and 20 carbons for use in promoting immune response and/or preventing and/or treating bacterial and/or viral infections.

##STR00001##

The present invention relates generally to the field of compositions for use in diagnostic methods. In particular, the present invention relates to a composition for use in a diagnostic method wherein the composition is a nutritional composition comprising 15-70 g fat, 60-90 g carbohydrates and 15-35 g protein. The diagnostic method may be a method to predict the risk of atheroma plaque presence in a subject.

The present invention relates generally to the field of compositions for use in diagnostic methods. In particular, the present invention relates to a composition for use in a diagnostic method wherein the composition is a nutritional composition comprising 15-70 g fat, 60-90 g carbohydrates and 15-35 g protein. The diagnostic method may be a method to predict the risk of atheroma plaque presence in a subject.

A method for treating Moringa seeds is disclosed. A starting material comprising ground Moringa seeds, preferably seeds that have undergone a process to remove their oil, is contacted with water. The water is drained, and the Moringa seeds are then contacted with water a second time. The product may then be dried or passed to an extruder. The process almost completely removes the unpleasant bitter taste associated with Moringa seeds, but retains most of the protein content of the starting material. In contrast to methods known in the art, the method does not require adjustment of the pH or the use of any organic solvent. A composition comprising ground Moringa seeds that comprises at least 30% protein and has a glucosinolate concentration <10% of that of naturally-occurring Moringa seeds, while lacking the bitter taste associated with raw Moringa seeds, is also disclosed.

A method for treating Moringa seeds is disclosed. A starting material comprising ground Moringa seeds, preferably seeds that have undergone a process to remove their oil, is contacted with water. The water is drained, and the Moringa seeds are then contacted with water a second time. The product may then be dried or passed to an extruder. The process almost completely removes the unpleasant bitter taste associated with Moringa seeds, but retains most of the protein content of the starting material. In contrast to methods known in the art, the method does not require adjustment of the pH or the use of any organic solvent. A composition comprising ground Moringa seeds that comprises at least 30% protein and has a glucosinolate concentration <10% of that of naturally-occurring Moringa seeds, while lacking the bitter taste associated with raw Moringa seeds, is also disclosed.

A food bar includes a mixture of dry ingredients including a protein and a binder including a sweetener. The food bar is able to maintain an initial texture so that the amount of force required to cut the food bar after storage of the food bar is substantially the same as the amount of force required to cut the food bar initially.